Search & Analyze
Popular Searches
Bio Medica Laboratories Ltd.
Healthcare₹138.95
CMP₹138.95
Mkt Cap₹175 Cr
P/E17.84
P/B9.64
ROE99.59%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
17.84
P/B Ratio
9.64
EV/EBITDA
12.24
Price/Sales
4.57
Dividend Yield (%)
0.00
EPS (TTM ₹)
7.79
Book Value (₹)
14.42
ROE (%)
99.59
ROCE (%)
64.18
ROA (%)
33.60
EBITDA Margin (%)
40.25
Net Profit Margin (%)
25.64
Debt/Equity
1.02
Current Ratio
1.83
Interest Coverage
10.70
Asset Turnover
1.31
Working Capital/Sales
2.71
Core EBITDA Growth (%)
170.72
P&L
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Gross Sales | 1622.82 | 1524.94 | 3819.52 |
| Net Sales | 1622.82 | 1524.94 | 3819.52 |
| Total Income | 1624.96 | 1534.43 | 3832.5 |
| Total Expenditure | 1452.83 | 961.79 | 2282.25 |
| Operating Profit | 172.13 | 572.64 | 1550.25 |
| Depreciation | 49.67 | 111 | 100.54 |
| Exceptional Items | — | — | — |
| Profit Before Tax | 45.21 | 365.04 | 1314.27 |
| Tax | 11.86 | 115.17 | 334.78 |
| Profit After Tax (PAT) | 33.35 | 249.87 | 979.49 |
| EPS (₹) | 0.36 | 2.72 | 10.67 |
| Dividend Payout % | — | — | — |
Balance Sheet
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Share Capital | 10 | 10 | 918 |
| Reserves | 233.95 | 483.81 | 555.3 |
| Shareholders Funds | 243.95 | 493.81 | 1473.3 |
| Total Debt | 960.67 | 1048.99 | 1501.44 |
| Total Liabilities | 1753.37 | 1940.15 | 3890.12 |
| Total Assets | 1753.37 | 1940.15 | 3890.12 |
| Book Value / Share | 243.95 | 493.81 | 16.049 |
| Assets | 1753.37 | 1940.15 | 3890.12 |
Cash Flows
| Particulars | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|
| Operating Activities | 229.31 | 162.41 | -367.17 |
| Investing Activities | -168.97 | -153.75 | 33.88 |
| Financing Activities | -212.54 | -8.25 | 332.94 |
| Net Cash Flow | -152.2 | 0.41 | -0.35 |
BMLL
₹138.95
+0%